Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Capital One
COF
|
$445M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$405M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$387M |
| 4 |
Johnson & Johnson
JNJ
|
$256M |
| 5 |
O'Reilly Automotive
ORLY
|
$184M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
$536M |
| 2 |
NVIDIA
NVDA
|
$471M |
| 3 |
X
US Steel
X
|
$421M |
| 4 |
JPMorgan Chase
JPM
|
$237M |
| 5 |
Deere & Co
DE
|
$235M |
Sector Composition
| 1 | Technology | 20.97% |
| 2 | Financials | 18.52% |
| 3 | Industrials | 12.28% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Healthcare | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Dominari Holdings
DOMH
$94M
| $79.5K | ﹤0.01% | 14,612 | – | – |
|
3202
Astrotech Corp
ASTC
$8.72M
| $79.5K | ﹤0.01% | 13,759 +1,677 | +14% | +$9.69K |
|
3203
SPAR Group
SGRP
$28.2M
| $79.1K | ﹤0.01% | 82,400 -5,599 | -6% | -$5.38K |
|
3204
SOPHiA GENETICS
SOPH
$234M
| $77.9K | ﹤0.01% | 25,127 | – | – |
|
3205
Stabilis Solutions
SLNG
$75.7M
| $77.5K | ﹤0.01% | 16,316 | – | – |
|
3206
Neumora Therapeutics
NMRA
$280M
| $77K | ﹤0.01% | 104,983 -83,435 | -44% | -$61.2K |
|
3207
Empire Petroleum
EP
$171M
| $76.6K | ﹤0.01% | 14,460 -4,406 | -23% | -$23.3K |
|
3208
DiaMedica Therapeutics
DMAC
$295M
| $75.4K | ﹤0.01% | 19,339 | – | – |
|
3209
Lipocine
LPCN
$15.8M
| $75.4K | ﹤0.01% | 23,862 -1,073 | -4% | -$3.39K |
|
3210
ThredUp
TDUP
$1.33B
| $75K | ﹤0.01% | 10,055 -66,449 | -87% | -$496K |
|
3211
Lisata Therapeutics
LSTA
$19.9M
| $74.3K | ﹤0.01% | 25,793 +571 | +2% | +$1.64K |
|
|
IMMP
3212
Immutep
IMMP
$234M
| $74.1K | ﹤0.01% | 45,167 -322 | -0.7% | -$528 |
|
3213
Ideal Power
IPWR
$44.5M
| $72K | ﹤0.01% | 15,889 +5,578 | +54% | +$25.3K |
|
3214
Usio Inc
USIO
$39.2M
| $71K | ﹤0.01% | 46,421 | – | – |
|
3215
Protalix BioTherapeutics
PLX
$124M
| $67.7K | ﹤0.01% | +45,571 | New | +$67.7K |
|
3216
Sera Prognostics
SERA
$123M
| $66.9K | ﹤0.01% | 22,424 -14,005 | -38% | -$41.8K |
|
3217
Ironwood Pharmaceuticals
IRWD
$214M
| $64.8K | ﹤0.01% | 90,373 -28 | -0% | -$20 |
|
|
ALMS
3218
Alumis Inc. Common Stock
ALMS
$479M
| $64.6K | ﹤0.01% | +21,540 | New | +$64.6K |
|
3219
enVVeno Medical
NVNO
$15.4M
| $64.3K | ﹤0.01% | 16,119 | – | – |
|
3220
Biomea Fusion
BMEA
$116M
| $63.8K | ﹤0.01% | 35,411 -23,897 | -40% | -$43K |
|
|
CNF
3221
CNFinance Holdings
CNF
$28.1M
| $62.6K | ﹤0.01% | 96,510 -53,789 | -36% | -$34.9K |
|
3222
Zynex
ZYXI
$49.7M
| $61.7K | ﹤0.01% | 23,924 -8 | -0% | -$21 |
|
3223
KLX Energy Services
KLXE
$35M
| $61.1K | ﹤0.01% | 32,667 -20,188 | -38% | -$37.8K |
|
3224
Barnwell Industries
BRN
$11.5M
| $60.7K | ﹤0.01% | 53,704 | – | – |
|
3225
Orchestra BioMed
OBIO
$147M
| $59.7K | ﹤0.01% | +22,207 | New | +$59.7K |
|